Status:
UNKNOWN
Effectiveness of Vitamin E and Hydrogen-Rich Water on Radiation Therapy-Induced Adverse In Patients With Rectal Cancer
Lead Sponsor:
University of Jordan
Collaborating Sponsors:
Slovak Academy of Sciences
Al-Quds University
Conditions:
Radiation-induced Injuries in Patients With Rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Controlled studies investigating the effects of vitamin E or H2 water or comparing their effectiveness on radiation therapy-induced injuries in RC patients are generally lacking. The present study hyp...
Eligibility Criteria
Inclusion
- \- Men or women.
- Older than 18 years.
- Histologically proven adenocarcinoma of the rectum.
- Underwent radiotherapy.
- Absence of any psychological, and sociological condition that potentially affects the compliance with the study protocol and follow-up schedule.
Exclusion
- The use of anticoagulant and antiplatelet agents.
- Any disease of disorder capable of contraindicating the absorption of Vitamin E or Hydrogen water in the body of a patient being investigated.
- No known history of problems absorbing fats (e.g., Crohn disease, cystic fibrosis)
Key Trial Info
Start Date :
July 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 8 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04713332
Start Date
July 6 2019
End Date
May 8 2021
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Augusta Victoria Hospital
East Jerusalem, Palestinian Territories